M Lucchi

Summary

Affiliation: University of Pisa
Country: Italy

Publications

  1. ncbi request reprint Small cell lung carcinoma (SCLC): the angiogenic phenomenon
    Marco Lucchi
    Cardiac and Thoracic Department, Division of Thoracic Surgery, University of Pisa, Via Paradisa 2, Italy
    Eur J Cardiothorac Surg 21:1105-10. 2002
  2. pmc Thymectomy for thymoma and myasthenia gravis. A survey of current surgical practice in thymic disease amongst EACTS members
    Marco Lucchi
    Division of Thoracic Surgery, University of Pisa, Pisa, Italy
    Interact Cardiovasc Thorac Surg 14:765-70. 2012
  3. doi request reprint Surgical treatment of recurrent thymomas
    Marco Lucchi
    Division of Thoracic Surgery, Cardiac and Thoracic Department, University of Pisa, Pisa, Italy
    J Thorac Oncol 5:S348-51. 2010
  4. ncbi request reprint Metachronous adrenal masses in resected non-small cell lung cancer patients: therapeutic implications of laparoscopic adrenalectomy
    Marco Lucchi
    Division of Thoracic Surgery, Cardiac and Thoracic Department, University of Pisa, Via Paradisa 2, Pisa 56124, Italy
    Eur J Cardiothorac Surg 27:753-6. 2005
  5. ncbi request reprint Advanced stage thymomas and thymic carcinomas: results of multimodality treatments
    Marco Lucchi
    Division of Thoracic Surgery, Cardiac and Thoracic Department, University of Pisa, Pisa, Italy
    Ann Thorac Surg 79:1840-4. 2005
  6. ncbi request reprint Thymomas: clinical-pathological correlations
    M Lucchi
    Unit of Thoracic Surgery, Cardiac and Thoracic Department, University of Pisa, Pisa, Italy
    J Cardiovasc Surg (Torino) 47:89-93. 2006
  7. ncbi request reprint A phase II study of intrapleural immuno-chemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy and long-term sub-cutaneous IL-2 in stage II-III malignant pleural mesothelioma
    Marco Lucchi
    Division of Thoracic Surgery, Cardiac and Thoracic Department, University of Pisa, Pisa, Italy
    Eur J Cardiothorac Surg 31:529-33; discussion 533-4. 2007
  8. ncbi request reprint Neoadjuvant chemotherapy for stage III and IVA thymomas: a single-institution experience with a long follow-up
    Marco Lucchi
    Division of Thoracic Surgery, Cardiac and Thoracic Departmen, University of Pisa, Pisa, Italy
    J Thorac Oncol 1:308-13. 2006
  9. ncbi request reprint Four-modality therapy in malignant pleural mesothelioma: a phase II study
    Marco Lucchi
    Division of Thoracic Surgery, Cardiac and Thoracic Department, University of Pisa, Italy
    J Thorac Oncol 2:237-42. 2007
  10. ncbi request reprint Sentinel lymph node mapping: detection of micrometastases by polymerase chain reaction in non-small cell lung cancer
    M Lucchi
    Division of Thoracic Surgery, Cardiac and Thoracic Department, University of Pisa, Pisa, Italy
    J Thorac Oncol 2:S37. 2007

Collaborators

Detail Information

Publications57

  1. ncbi request reprint Small cell lung carcinoma (SCLC): the angiogenic phenomenon
    Marco Lucchi
    Cardiac and Thoracic Department, Division of Thoracic Surgery, University of Pisa, Via Paradisa 2, Italy
    Eur J Cardiothorac Surg 21:1105-10. 2002
    ..We reviewed our experience in the surgical treatment of SCLC with particular reference to the angiogenetic expression and its correlation to the stage of disease and prognosis...
  2. pmc Thymectomy for thymoma and myasthenia gravis. A survey of current surgical practice in thymic disease amongst EACTS members
    Marco Lucchi
    Division of Thoracic Surgery, University of Pisa, Pisa, Italy
    Interact Cardiovasc Thorac Surg 14:765-70. 2012
    ..01), induction therapy (P = 0.05) and are more likely to have access to a tissue bank (P = 0.04). Both in thymoma and MG surgery, cooperative prospective studies seem to be feasible in dedicated thoracic surgical associations as EACTS...
  3. doi request reprint Surgical treatment of recurrent thymomas
    Marco Lucchi
    Division of Thoracic Surgery, Cardiac and Thoracic Department, University of Pisa, Pisa, Italy
    J Thorac Oncol 5:S348-51. 2010
    ..We can conclude that reoperation for thymoma recurrences is feasible and relatively safe, and it should always be considered because the other treatment modalities are not curative...
  4. ncbi request reprint Metachronous adrenal masses in resected non-small cell lung cancer patients: therapeutic implications of laparoscopic adrenalectomy
    Marco Lucchi
    Division of Thoracic Surgery, Cardiac and Thoracic Department, University of Pisa, Via Paradisa 2, Pisa 56124, Italy
    Eur J Cardiothorac Surg 27:753-6. 2005
    ..We report our experience on laparoscopic adrenalectomy for suspected or confirmed metachronous solitary adrenal metastasis from NSCLC and discuss its therapeutic role...
  5. ncbi request reprint Advanced stage thymomas and thymic carcinomas: results of multimodality treatments
    Marco Lucchi
    Division of Thoracic Surgery, Cardiac and Thoracic Department, University of Pisa, Pisa, Italy
    Ann Thorac Surg 79:1840-4. 2005
    ..With the aim of evaluating the results of multidisciplinary approaches, we reviewed our experience in multimodality treatment of advanced stage (III and IVA) thymic tumors...
  6. ncbi request reprint Thymomas: clinical-pathological correlations
    M Lucchi
    Unit of Thoracic Surgery, Cardiac and Thoracic Department, University of Pisa, Pisa, Italy
    J Cardiovasc Surg (Torino) 47:89-93. 2006
    ..We present the results of a retrospective analysis on patients, operated on for a thymoma, whose specimens were available, to compare the WHO thymoma histologic classification to the clinical behavior of the tumors...
  7. ncbi request reprint A phase II study of intrapleural immuno-chemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy and long-term sub-cutaneous IL-2 in stage II-III malignant pleural mesothelioma
    Marco Lucchi
    Division of Thoracic Surgery, Cardiac and Thoracic Department, University of Pisa, Pisa, Italy
    Eur J Cardiothorac Surg 31:529-33; discussion 533-4. 2007
    ..In 1999, we started a phase II study based on the multimodality treatment of stage II-III MPM, the results of which have been analysed and reported...
  8. ncbi request reprint Neoadjuvant chemotherapy for stage III and IVA thymomas: a single-institution experience with a long follow-up
    Marco Lucchi
    Division of Thoracic Surgery, Cardiac and Thoracic Departmen, University of Pisa, Pisa, Italy
    J Thorac Oncol 1:308-13. 2006
    ..In this article, we review our long-term experience of neoadjuvant chemotherapy of advanced stage (III-IVA) thymomas...
  9. ncbi request reprint Four-modality therapy in malignant pleural mesothelioma: a phase II study
    Marco Lucchi
    Division of Thoracic Surgery, Cardiac and Thoracic Department, University of Pisa, Italy
    J Thorac Oncol 2:237-42. 2007
    ..In 1999, we began a phase II study to investigate four-modality treatment of advanced stage MPM...
  10. ncbi request reprint Sentinel lymph node mapping: detection of micrometastases by polymerase chain reaction in non-small cell lung cancer
    M Lucchi
    Division of Thoracic Surgery, Cardiac and Thoracic Department, University of Pisa, Pisa, Italy
    J Thorac Oncol 2:S37. 2007
  11. ncbi request reprint IIIB-T4 non-small cell lung cancer: indications and results of surgical treatment
    M Lucchi
    Division of Thoracic Surgery, Cardiac and Thoracic Department, University of Pisa, Pisa, Italy
    J Cardiovasc Surg (Torino) 48:369-74. 2007
    ..We have reviewed our experience with T4 NSCLC patients who underwent surgery with the aim of debating the indications and results of surgical treatment in this highly selected group of patients...
  12. ncbi request reprint Sleeve and wedge parenchyma-sparing bronchial resections in low-grade neoplasms of the bronchial airway
    Marco Lucchi
    Division of Thoracic Surgery, University of Pisa, Pisa, Italy
    J Thorac Cardiovasc Surg 134:373-7. 2007
    ..We reviewed our experience analyzing the indications, the operative technique, and the results of such operations...
  13. ncbi request reprint Four thymus-related syndromes in a case of invasive thymoma
    Marco Lucchi
    Division of Thoracic Surgery, Department of Cardiac and Thoracic Surgery, University of Pisa, Pisa, Italy
    J Thorac Cardiovasc Surg 134:1376-8. 2007
  14. doi request reprint Surgical treatment of pleural recurrence from thymoma
    Marco Lucchi
    Division of Thoracic Surgery, Cardiac and Thoracic Department, University of Pisa, Via Paradisa 2, Pisa 56124, Italy
    Eur J Cardiothorac Surg 33:707-11. 2008
    ..Our aim was to review the literature laying the stress on the incidence, diagnosis, treatment options and prognosis of this highly selected group of patients with pleural recurrence from thymoma...
  15. doi request reprint Association of thymoma and myasthenia gravis: oncological and neurological results of the surgical treatment
    Marco Lucchi
    Cardiac and Thoracic Department, Division of Thoracic Surgery, University of Pisa, Pisa, Italy
    Eur J Cardiothorac Surg 35:812-6; discussion 816. 2009
    ..Both diseases are treated by surgery. The aims of this study were to analyze the clinical features of these patients and the oncological and neurological outcomes after thymectomy...
  16. doi request reprint Multimodality treatment of malignant pleural mesothelioma with or without immunotherapy: does it change anything?
    Marco Lucchi
    Division of Thoracic Surgery, Department of Cardiac and Thoracic, Centro Polidisciplinare per la Ricerca, la Prevenzione, la Diagnosi e il Trattamento del Mesotelioma Pleurico Maligno e delle altre Neoplasie Amianto Correlate, Azienda Ospedaliero Universitaria Pisana, Italy
    Interact Cardiovasc Thorac Surg 10:572-6. 2010
    ..Changes in MPM microenvironment induced by immunotherapy may play a major role in the local control of this disease and need further investigations...
  17. ncbi request reprint Massive pneumoencephalus of late onset after an en bloc resection for lung cancer
    Marco Lucchi
    Division of Thoracic Surgery, Department of Cardiac and Thoracic Surgery, University of Pisa, Italy
    J Thorac Cardiovasc Surg 127:1836-8. 2004
  18. doi request reprint Management of pleural recurrence after curative resection of thymoma
    Marco Lucchi
    Division of Thoracic Surgery, Cardiac and Thoracic Department, University of Pisa, Pisa, Italy
    J Thorac Cardiovasc Surg 137:1185-9. 2009
    ..Unfortunately, there is no standard treatment for pleural recurrence. This article describes our overall experience with the surgical treatment of pleural implants in patients who previously underwent resection of a thymoma...
  19. ncbi request reprint Thymic carcinoma: a report of 13 cases
    M Lucchi
    Cardiac and Thoracic Department, Division of Thoracic Surgery, University of Pisa, Via Paradisa 2, Pisa 56124, Italy
    Eur J Surg Oncol 27:636-40. 2001
    ..Thymic carcinoma is a rare thymic neoplasm. It is more invasive and has a poorer prognosis than thymoma. We report our experience in the treatment of 13 thymic carcinomas...
  20. pmc A high vascular count and overexpression of vascular endothelial growth factor are associated with unfavourable prognosis in operated small cell lung carcinoma
    G Fontanini
    Department of Oncology, Transplants and Advanced Technologies in Medicine, University of Pisa, Via Roma 57, 56126 Pisa, Italy
    Br J Cancer 86:558-63. 2002
    ..001), suggesting that angiogenic phenomenon may have an important role in the clinical behaviour of this lung cancer subgroup...
  21. ncbi request reprint Thrombospondins I and II messenger RNA expression in lung carcinoma: relationship with p53 alterations, angiogenic growth factors, and vascular density
    G Fontanini
    Department of Oncology, University of Pisa, Italy
    Clin Cancer Res 5:155-61. 1999
    ....
  22. pmc Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression
    G Fontanini
    Institute of Pathology, University of Pisa, Italy
    Br J Cancer 75:1295-301. 1997
    ....
  23. ncbi request reprint Alterations of Fas (APO-1/CD 95) gene and its relationship with p53 in non small cell lung cancer
    L Boldrini
    Department of Oncology, Transplants and Advanced Technologies in Medicine, University of Pisa, Via Roma 57, 56126 Pisa, Italy
    Oncogene 20:6632-7. 2001
    ....
  24. pmc Expression of vascular endothelial growth factor mRNA in non-small-cell lung carcinomas
    G Fontanini
    Department of Oncology, University of Pisa, Italy
    Br J Cancer 79:363-9. 1999
    ..02) and disease-free survival (P = 0.03). As a regulator of tumour angiogenesis, VEGF may represent a useful indicator of progression and poor prognosis in non-small-cell lung carcinomas...
  25. pmc Tumour necrosis factor-alpha and transforming growth factor-beta are significantly associated with better prognosis in non-small cell lung carcinoma: putative relation with BCL-2-mediated neovascularization
    L Boldrini
    Department of Oncology, University of Pisa, Italy
    Br J Cancer 83:480-6. 2000
    ..05), suggesting that the favourable effect of TNF-alpha on clinical outcome may be related to a bcl-2-mediated low neovascular development...
  26. pmc Prognostic significance of osteopontin expression in early-stage non-small-cell lung cancer
    L Boldrini
    Division of Surgical Pathology, Department of Surgery, University of Pisa, Italy
    Br J Cancer 93:453-7. 2005
    ..This conclusion has notable importance in terms of the biological characterization of early-stage tumours and therapeutic opportunities...
  27. pmc Treatment with interleukin-2 in malignant pleural mesothelioma: immunological and angiogenetic assessment and prognostic impact
    G Ali
    Division of Pathological Anatomy, Department of Surgery, University of Pisa, Via Roma 57, Pisa 56126, Italy
    Br J Cancer 101:1869-75. 2009
    ..The purpose of this study was to investigate the ability of IL-2 to modify immunological effector cells and angiogenesis in MPM patients and their prognostic value...
  28. ncbi request reprint The multimodality treatment of thymic carcinoma
    M Lucchi
    Cardiac and Thoracic Department, Division of Thoracic Surgery, University of Pisa, Pisa, Italy
    Eur J Cardiothorac Surg 19:566-9. 2001
    ..Our experience, although preliminary, is encouraging and merits additional study in a multicenter trial with a sufficient number of patients to draw definitive conclusions...
  29. ncbi request reprint Interleukin-8 in non-small cell lung carcinoma: relation with angiogenic pattern and p53 alterations
    Laura Boldrini
    Department of Surgery, University of Pisa, Pisa, Italy
    Lung Cancer 50:309-17. 2005
    ..However, in our samples IL-8 levels did not significantly affect prognosis of NSCLC; more studies are required to elucidate the precise role of IL-8 in a large series of patients with non-small cell lung carcinoma...
  30. pmc Bcl-2 protein: a prognostic factor inversely correlated to p53 in non-small-cell lung cancer
    G Fontanini
    Institute of Pathology, University of Pisa, Italy
    Br J Cancer 71:1003-7. 1995
    ..An inverse relationship was also found between Bcl-2 and the anti-oncogene protein product p53 (P = 0.01). Thus, a high proportion of NSCLCs express p53 and Bcl-2 proteins and their expression may have prognostic importance...
  31. doi request reprint Tryptase mast cells in malignant pleural mesothelioma as an independent favorable prognostic factor
    Greta Alì
    Division of Pathological Anatomy, Department of Surgery, University of Pisa, Pisa, Italy
    J Thorac Oncol 4:348-54. 2009
    ..The purpose of this study was to determine the presence and prognostic significance of tumor infiltrating mast cells in mesothelioma...
  32. ncbi request reprint Videothoracoscopy for evaluation and treatment of hemothorax
    M C Ambrogi
    Division of Thoracic Surgery, Cardiac and Thoracic Department, University of Pisa, Pisa, Italy
    J Cardiovasc Surg (Torino) 43:109-12. 2002
    ..The first step of management is the placement of a tube thoracostomy which is efficacious in more than 80% of cases. Continuous bleeding and retained blood, instead, require surgical treatment...
  33. ncbi request reprint Gastropleural fistula as complication of postpneumonectomy empyema
    A Mussi
    Department of Cardiothoracic Surgery, University of Pisa, Italy
    J Cardiovasc Surg (Torino) 41:147-9. 2000
    ..Three months after discharge the patient noticed the presence of ingesta in the pleural washing fluid. Diagnostic and operative procedures in this rare case of non malignant, non traumatic gastropleural fistula are described...
  34. ncbi request reprint A strategy for thoracoscopic resection of small pulmonary nodules
    M C Ambrogi
    Division of Thoracic Surgery, Cardiac and Thoracic Department, University of Pisa, Via Paradisa, 2, 56124, Pisa, Italy
    Surg Endosc 19:1644-7. 2005
    ..The aim of this report is to describe the strategy we developed to limit preoperative techniques without reducing the thoracoscopic success rate of localization...
  35. ncbi request reprint Identification of Fas (APO-1/CD95) and p53 gene mutations in non-small cell lung cancer
    L Boldrini
    Department of Oncology, Transplants and Advanced Technologies in Medicine, Pisa, Italy
    Int J Oncol 20:155-9. 2002
    ..5%). These data increase the knowledge regarding mutations of apoptosis-genes involved in the pathogenesis of NSCLC, and give benefits for the clinical management of this type of tumor...
  36. ncbi request reprint Extended thymectomy in myasthenia gravis: a team-work of neurologist, thoracic surgeon and anaesthesist may improve the outcome
    A Mussi
    Cardiac and Thoracic Department, Division of Thoracic Surgery, University of Pisa, Via Paradisa 2, 56124, Pisa, Italy
    Eur J Cardiothorac Surg 19:570-5. 2001
    ....
  37. ncbi request reprint Acute major airway injuries: clinical features and management
    A Mussi
    Division of Thoracic Surgery, Cardiac and Thoracic Department, University of Pisa, Pisa, Italy
    Eur J Cardiothorac Surg 20:46-51, discussion 51-2. 2001
    ..The conservative treatment should be reserved to those patients with minimal signs and symptoms, and with an adequate patency of the airways...
  38. ncbi request reprint Gamma probe-guided thoracoscopic surgery of small pulmonary nodules
    G Boni
    Department of Oncology, University of Pisa, Italy
    Tumori 86:364-6. 2000
    ..In conclusion, the radiolocalization of small pulmonary nodules by gamma probe during VATS is a safe and easy procedure, with fewer complications and a lower failure rate than other localization techniques...
  39. doi request reprint Effect of the p53 codon 72 and intron 3 polymorphisms on non-small cell lung cancer (NSCLC) prognosis
    Laura Boldrini
    Department of Surgery, University of Pisa, Pisa, Italy
    Cancer Invest 26:168-72. 2008
    ..This approach highlights the value of examining multiple polymorphisms in genes to improve survival estimates...
  40. ncbi request reprint Comparison between plasma and serum osteopontin levels: usefulness in diagnosis of epithelial malignant pleural mesothelioma
    Alfonso Cristaudo
    Department of Endocrinology and Metabolism, Orthopedics and Traumatology, Occupational Medicine, University of Pisa, Pisa, Italy
    Int J Biol Markers 25:164-70. 2010
    ....
  41. ncbi request reprint Expression of endothelin-1 is related to poor prognosis in non-small cell lung carcinoma
    Laura Boldrini
    Department of Surgery, University of Pisa, 56100 Pisa, Italy
    Eur J Cancer 41:2828-35. 2005
    ..04, respectively). We conclude that ET-1 could be involved in angiogenic phenomena in NSCLC and may represent a further indicator of progression and poor prognosis in this type of cancer, with interesting therapeutic implications...
  42. doi request reprint Different estrogen receptor beta expression in distinct histologic subtypes of lung adenocarcinoma
    Greta Alì
    Department of Surgery, Division of Anatomic Pathology, University of Pisa, 56126 Pisa, Italy
    Hum Pathol 39:1465-73. 2008
    ..Moreover, loss of estrogen receptor beta expression in poorly differentiated (G3) tumors could represent a crucial step in the dedifferentiation process of lung adenocarcinoma...
  43. doi request reprint Intraoperative sentinel lymph node mapping in stage I non-small cell lung cancer: detection of micrometastases by polymerase chain reaction
    Franca M A Melfi
    Division of Thoracic Surgery, Cardiac and Thoracic Department, University of Pisa, Italy
    Eur J Cardiothorac Surg 34:181-6. 2008
    ..We applied the molecular techniques (RT-PCR) to improve the detection of micrometastasis in order to evaluate an improvement of staging in early non-small cell lung cancer (NSCLC) patients (pts)...
  44. ncbi request reprint Epidermal growth factor receptor and K-RAS mutations in 411 lung adenocarcinoma: a population-based prospective study
    Laura Boldrini
    Department of Surgery, University of Pisa, Pisa, Italy
    Oncol Rep 22:683-91. 2009
    ....
  45. ncbi request reprint Prognostic impact of p53 Pro72 homozygous genotype in non-small cell lung cancer patients
    Laura Boldrini
    Department of Surgery, University of Pisa, 56126 Pisa, Italy
    Oncol Rep 19:771-3. 2008
    ..Our results may help clarify discrepancies in the literature concerning the prognostic role of p53 codon 72 variants...
  46. ncbi request reprint CDC25B: relationship with angiogenesis and prognosis in non-small cell lung carcinoma
    Laura Boldrini
    Department of Surgery, University of Pisa, 56126 Pisa, Italy
    Hum Pathol 38:1563-8. 2007
    ....
  47. ncbi request reprint Percutaneous radiofrequency ablation of lung tumours: results in the mid-term
    Marcello Carlo Ambrogi
    Cardiac and Thoracic Department, Via Paradisa 2, 56124 Pisa, Italy
    Eur J Cardiothorac Surg 30:177-83. 2006
    ..Herein, we report the 5 years experience of a single referral centre in Europe, with particular reference to the mid-term results...
  48. ncbi request reprint Expression and mutational status of c-kit in small-cell lung cancer: prognostic relevance
    Laura Boldrini
    Departments of Surgery, Oncology, Transplants and Advanced Technologies in Medicine, and Cardio Thoracic Surgery, University of Pisa, Pisa, Italy
    Clin Cancer Res 10:4101-8. 2004
    ..We examined c-kit expression and mutational status in SCLC to verify its putative expression and genetic alterations, as well as its eventual prognostic impact...
  49. ncbi request reprint Tumour necrosis factor-alpha: prognostic role and relationship with interleukin-8 and endothelin-1 in non-small cell lung cancer
    Laura Boldrini
    Department of Surgery, University of Pisa, I 56126 Pisa, Italy
    Int J Mol Med 17:887-92. 2006
    ..Our study may also contribute to advancing the knowledge of the molecular relationship between cytokines and endothelial functions in NSCLC...
  50. ncbi request reprint Osteopontin expression and prognostic significance in non-small cell lung cancer
    Valentina Donati
    Division of Surgical Pathology, Departments of Surgery, University of Pisa, Italy
    Clin Cancer Res 11:6459-65. 2005
    ..The purpose of this study was to better define the role of osteopontin in non-small cell lung cancer biology by determining its prognostic significance...
  51. ncbi request reprint A reappraisal of the indications for laparoscopic treatment of adrenal metastases
    Paolo Miccoli
    Department of General Surgery, University of Pisa, Italy
    J Laparoendosc Adv Surg Tech A 14:139-45. 2004
    ..The possible role of fine needle aspiration biopsy (FNAB) in selecting patients was evaluated...
  52. doi request reprint Pharmacokinetics of azithromycin in serum, bronchial washings, alveolar macrophages and lung tissue following a single oral dose of extended or immediate release formulations of azithromycin
    M Lucchi
    Division of Thoracic Surgery, Cardiothoracic Department, University of Pisa, Via Paradisa 2, 56124 Pisa, Italy
    J Antimicrob Chemother 61:884-91. 2008
    ....
  53. ncbi request reprint Applications of tissue microarray technology in immunohistochemistry: a study on c-kit expression in small cell lung cancer
    Valentina Donati
    Department of Surgery, Division of Surgical Pathology, University of Pisa, Italy
    Hum Pathol 35:1347-52. 2004
    ..4%). Moreover, a high percentage (13.4%) of cores was lost, and this loss was not random. To sum up, in our experience, tissue microarray technology cannot be a substitute for whole sections in clinical diagnosis of individual cases...
  54. ncbi request reprint WWOX expression in different histologic types and subtypes of non-small cell lung cancer
    Valentina Donati
    Department of Surgery, Division of Anatomic Pathology and Cardio Thoracic Surgery, University of Pisa and Scuola Normale Superiore and Istituto Nazionale di Fisica Nucleare, Section of Pisa, Pisa, Italy
    Clin Cancer Res 13:884-91. 2007
    ..The purpose of this study is to better define the role of WWOX in NSCLC tumorigenesis and progression by determining its pathogenetic and prognostic significance...
  55. ncbi request reprint Laser capture microdissection: a tool for the molecular characterization of histologic subtypes of lung adenocarcinoma
    Valentina Donati
    Section of Pathological Anatomy II, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy
    Int J Mol Med 24:473-9. 2009
    ....
  56. ncbi request reprint Thymectomy in ocular myasthenia gravis
    Marco Lucchi
    J Thorac Cardiovasc Surg 125:740-1; author reply 741. 2003
  57. ncbi request reprint [Management of spontaneous pneumothorax: nationwide fact-finding survey among Italian thoracic surgery units]
    Mark Ragusa
    Universita degli Studi di Perugia, Sede di Perugia, SC di Chirurgia Toracica, Perugia
    Chir Ital 59:627-34. 2007
    ..It is the authors' opinion that further work is needed in order to achieve a greater measure of agreement in the management of primary and secondary pneumothorax...